ENTITY
Grifols

Grifols (GRFS US)

41
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Henkel & KGaA
•17 Sep 2024 23:58

Liquid Universe of European Ordinary and Preferred Shares: September‘24 Report

Since mid-August, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (13 have...

Share
bullish•Grifols SA
•30 Aug 2024 21:15

Brookfield Explores Sovereign Funds for Grifols Takeover Bid

Press reports Brookfield is seeking support from sovereign wealth funds, including those from Abu Dhabi (ADQ) and Singapore (GIC), to back its bid,...

Share
bullish•Grifols SA
•23 Aug 2024 05:45

Brookfield/Grifols: Update & Recap, Spread, Discount

Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private...

Share
bullish•Grifols
•19 Aug 2024 17:48

Liquid Universe of European Ordinary and Preferred Shares: August‘24 Report

Since mid-July, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have tightened,...

Share
bullish•Grifols
•18 Jul 2024 19:44

Liquid Universe of European Ordinary and Preferred Shares: July‘24 Report

Since mid-June, share-price spreads have generally tightened across our European liquid universe of ordinary and preferred shares (13 have...

Share
x